SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-19-041819
Filing Date
2019-11-07
Accepted
2019-11-07 16:37:58
Documents
80
Period of Report
2019-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q eypt-10q_20190930.htm 10-Q 2290236
2 EX-31 eypt-ex31_11.htm EX-31 15789
3 EX-32 eypt-ex32_8.htm EX-32 6863
  Complete submission text file 0001564590-19-041819.txt   9176485

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE DOCUMENT eypt-20190930.xml EX-101.INS 1936502
5 XBRL TAXONOMY EXTENSION SCHEMA eypt-20190930.xsd EX-101.SCH 91000
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE eypt-20190930_cal.xml EX-101.CAL 51541
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE eypt-20190930_def.xml EX-101.DEF 334018
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE eypt-20190930_lab.xml EX-101.LAB 616546
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE eypt-20190930_pre.xml EX-101.PRE 497211
Mailing Address 480 PLEASANT STREET SUITE B300 WATERTOWN MA 02472
Business Address 480 PLEASANT STREET SUITE B300 WATERTOWN MA 02472 617-926-5000
EyePoint Pharmaceuticals, Inc. (Filer) CIK: 0001314102 (see all company filings)

IRS No.: 262774444 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-51122 | Film No.: 191200930
SIC: 3826 Laboratory Analytical Instruments